Tingliang Zhuang

Tingliang Zhuang

Auto-generated profile, based on publicly available information

Tingliang Zhuang

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2013 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
TZTingliang Zhuang
Tingliang Zhuang
TDToufik Djemil
Toufik Djemil
PQPeng Qi
Peng Qi
AMAnthony Magnelli
Anthony Magnelli
KSKevin Stephans
Kevin Stephans
PXPing Xia
Ping Xia
Stereotactic body radiation therapy (SBRT) has been increasingly used as an efficacious treatment modality for early-stage non-small cell lung cancer. The accuracy of dose calculations is compromised due to the presence of inhomogeneity. For the purpose of a consistent prescription, radiation doses were calculated without heterogeneity correction in several RTOG trials. For patients participating in these trials, recalculations of the planned doses with more accurate dose methods could provide better correlations between the treatment outcomes and the planned doses. Using a Monte Carlo (MC) dose calculation algorithm as a gold standard, we compared the recalculated doses with the MC algorithm to the original pencil beam (PB) calculations for our institutional clinical lung SBRT plans. The focus of this comparison is to investigate the volume and location dependence on the differences between the two dose calculations. Thirty-one clinical plans that followed RTOG and other protocol guidelines were retrospectively investigated in this study. Dosimetric parameters, such as D1 , D95 , and D99 for the PTV and D1 for organs at risk, were compared between two calculations. Correlations of mean lung dose and V20 of lungs between two calculations were investigated. Significant dependence on tumor size and location was observed from the comparisons between the two dose calculation methods. When comparing the PB calculations without heterogeneity correction to the MC calculations with heterogeneity correction, we found that in terms of D95 of PTV: (1) the two calculations resulted in similar D95 for edge tumors with volumes greater than 25.1 cc; (2) an average overestimation of 5% in PB calculations for edge tumors with volumes less than 25.1 cc; and (3) an average overestimation of 9% or underestimation of 3% in PB calculations for island tumors with volumes smaller or greater than 22.6 cc, respectively. With heterogeneity correction, the PB calculations resulted in an average reduction of 23.8% and 15.3% in the D95 for the PTV for island and edge lesions, respectively, when compared to the MC calculations. For organs at risks, very small differences were found among all the comparisons. Excellent correlations for mean dose and V20 of lungs were observed between the two calculations. This study demonstrated that using a single scaling factor may be overly simplified when accounting for the effects of heterogeneity correction. Accurate dose calculations, such as the Monte Carlo algorithms, are highly recommended to understand dose responses in lung SBRT. PACS number: 87.53.Ly

4 April 2024 in Practical Radiation Oncology
Verified
Journal Article
Closed access
RLRuiqi Li
Ruiqi Li
TZTingliang Zhuang
Tingliang Zhuang
SMSteven Montalvo
Steven Montalvo
KWKai Wang
Kai Wang
DPDavid Parsons
David Parsons
KWKenneth Westover
Kenneth Westover

1 October 2017 in Physica Medica
Verified
Journal Article
Closed access
PDF file
HLHan Liu
Han Liu
MAMartin Andrews
Martin Andrews
AMAndrey Markovich
Andrey Markovich
TZTingliang Zhuang
Tingliang Zhuang

1 February 2024 in Biomedical Physics & Engineering Express
Verified
Journal Article
Closed access
TZTingliang Zhuang
Tingliang Zhuang
DPDavid Parsons
David Parsons
NDNeil Desai
Neil Desai
GGGrant Gibbard
Grant Gibbard
DKDana Keilty
Dana Keilty
SJSteve Jiang
Steve Jiang
This study explored the feasibility of on-couch intensity modulated radiotherapy (IMRT) planning for prostate cancer (PCa) on a cone-beam CT (CBCT)-based online adaptive RT platform without an individualized pre-treatment plan and contours. Ten patients with PCa previously treated with image-guided IMRT (60 Gy/20 fractions) were selected. In contrast to the routine online adaptive RT workflow, a novel approach was employed in which the same preplan that was optimized on one reference patient was adapted to generate individual on-couch/initial plans for the other nine test patients using Ethos emulator. Simulation CTs of the test patients were used as simulated online CBCT (sCBCT) for emulation. Quality assessments were conducted on synthetic CTs (sCT). Dosimetric comparisons were performed between on-couch plans, on-couch plans recomputed on the sCBCT and individually optimized plans for test patients. The median value of mean absolute difference between sCT and sCBCT was 74.7 HU (range 69.5–91.5 HU). The average CTV/PTV coverage by prescription dose was 100.0%/94.7%, and normal tissue constraints were met for the nine test patients in on-couch plans on sCT. Recalculating on-couch plans on the sCBCT showed about 0.7% reduction of PTV coverage and a 0.6% increasing of hotspot, and the dose difference of the OARs was negligible (<0.5 Gy). Hence, initial IMRT plans for new patients can be generated by adapting a reference patient’s preplan with online contours, which had similar qualities to the conventional approach of individually optimized plan on the simulation CT. Further study is needed to identify selection criteria for patient anatomy most amenable to this workflow.

1 October 2018
Verified
Book
Closed access
PXPing Xia
Ping Xia
AGAndrew Godley
Andrew Godley
CSChirag Shah
Chirag Shah
GVGregory M. M. Videtic
Gregory M. M. Videtic
JSJohn H. Suh
John H. Suh
SRSaju Rajan
Saju Rajan
This book details the technical aspects of how to achieve requirements for clinical treatment planning aspects, including patient positioning, creation of patient specific bolus, beam angle configurations, and inverse planning optimization approaches. It is written for everyone involved in treatment planning including dosimetrists, physicists, and physicians. The book comprises of 14 chapters. The first three chapters are introductory chapters. Chapter one describes the types of treatment plans and the general process of treatment planning. The second chapter explains the principles and limitations of current inverse planning optimization algorithms, and discusses the application of auto-planning, knowledge-based planning, and multi-criteria optimization to overcome these limitations. The third chapter covers the available immobilization equipment and general principles of simulation, including patient safety procedures. Chapters four through eleven are organized by body site or system and covers central nervous system, head and neck, breast cancer, thoracic cancer, gastrointestinal radiotherapy, genitourinary cancer, gynecologic cancer, lymphoma, and soft tissue sarcoma. For each site, there is a description of patient simulation, including immobilization, setup, isocenter placement, and any special considerations such as motion management. The plan goals for each treatment site are tabulated, followed by recipes to achieve them from the simplest planning technique to the most advanced planning technique. For simple 3D conformal plans, the recipes include the field arrangement and portal shape design (both with many figures), beam weighting, and selection of dose normalization point. For advanced techniques such as intensity-modulated radiation therapy, volumetric modulated radiation therapy, and stereotactic body radiation therapy, the recipes provide details of creation of optimization structures and multiple stage optimizations. Each chapter concludes with plan evaluation, comparing achieved doses to the clinical planning goals. Chapter thirteen describes treatment planning for pediatric cancers. Chapter fourteen discusses treatment planning for palliative treatment.

3 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
DWDa Wang
Da Wang
HKHeejung Kim
Heejung Kim
TZTingliang Zhuang
Tingliang Zhuang
JVJustin Visak
Justin Visak
BCBin Cai
Bin Cai
MLMu-Han Lin
Mu-Han Lin
Treatment planning in the field of radiation therapy has evolved from three-dimensional (3D) planning to inverse planning and, most recently, to personalized adaptive radiotherapy (ART)